CFN Media sits down for an exclusive interview with InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). (VIDEO)
CFN Media sits down for an exclusive interview with InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). (VIDEO)
Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. has a potentially wide range of applications in the cannabis market.
MedReleaf Corp. Announces $100.5 Million Bought Deal Financing
AV1 Group (OTC: AVOP) is building its focus of identifying, securing and monetizing companies with emerging growth potential.
With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management.
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.
What the California Fires Mean for the Weed Industry
SinglePoint is very close to launching its own bitcoin exchange aimed at solving the current problems of unbankability for cannabis businesses in the United States.
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited.
Grey Cloak Tech recently entered the booming cannabis industry through the strategic acquisition of a medically-focused CBD company, Eqova Life Sciences.
PotNetwork Holding (OTC: POTN) this morning announced that Diamond CBD, Inc., the company’s wholly owned subsidiary, reported revenues for October of nearly $1.7 million.
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
Cannabis companies have ramped up their efforts to make new scientific discoveries related to the plant’s medical uses.
PotNetwork Holding Inc. recently published estimates by Hemp Business Journal suggesting that hemp-based CBD will be a $1.8 billion market by 2020.